Achieving Outcomes:
Best Practices in the
Management of Cancer Pain

RELEASE DATE: October 2003
EXPIRATION DATE: October 31, 2004

Underrecognition and undertreatment of acute and chronic cancer pain are common occurrences. Barriers to appropriate treatment include lack of awareness of the principles and benefits of cancer pain therapy among patients and their families, and among many clinicians. Education of patients and their families, and of healthcare providers, is essential to improve the treatment of cancer pain. Essential components of improved therapy include quantitative assessment of pain and eliminating the "fear" of opioid therapy. This review is designed to help clinicians recognize the need for patient education and patient participation in selection and administration of analgesic regimens, and to provide such therapy according to current published guidelines.

This educational activity is intended for physicians, pharmacists, and nurses involved in the management of patients with cancer.

At the completion of this activity, participants should be able to:

  1. Describe current guidelines for the treatment of patients with cancer pain
  2. Identify specific concerns and recommendations related to the use of opioid analgesics among cancer patients
  3. Apply recommendations for detection and quantitative evaluation of pain in all cancer patients, with particular attention to minority patients


This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Dannemiller Memorial Educational Foundation and McMahon Publishing Group. The Dannemiller Memorial Educational Foundation is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit—Physicians
The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Only US licensed physicians may be awarded AMA PRA category 1 credit by accredited providers. Certificates of participation may be provided to all other health professionals.

Accreditation/Designation of Credit—Nurses
The Dannemiller Memorial Educational Foundation is an approved provider of the California Board of Registered Nursing. Provider approved by the California Board of Registered Nursing, Provider Number 4229, for 1 contact hour.

Accreditation/Designation of Credit—Pharmacists
Purdue University is accredited by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. This is a continuing education activity of Purdue, an equal access/equal opportunity university. To receive the 1 contact hour of continuing education credit, pharmacists should complete the activity requirements and evaluation at the conclusion of the monograph. Approval is valid from the initial release date of October 23, 2003. The expiration date is October 31, 2004. Program Number 018-999-03-103-H01.

This activity should take approximately 1 hour to complete. The participant should, in order, read the objectives, other introductory material, and online monograph, answer the 10-question multiple-choice online post-test, and complete the evaluation. The evaluation form provides each participant with the opportunity to comment on the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his/her views on future educational needs. To receive credit for this activity, follow the post-test instructions. There is no fee associated with this activity. This credit will be valid through October 31, 2004. No credit will be given after this date.

For questions regarding the content of this activity, contact Dannemiller Memorial Educational Foundation, accredited provider for this activity, at For technical assistance, contact

Internet Explorer (v5.5 or greater) or Netscape (v7.2 or greater)
Adobe Acrobat Reader
Windows 98, SE or above; OR Mac 10.2; 800 x 600 minimum monitor resolution (1024 x 768 recommended)

Betty Ferrell, PhD, FAAN
Research Scientist
City of Hope Medical Center
Duarte, California

Andre Weinberger, MD

It is the policy of the Dannemiller Memorial Educational Foundation that faculty participating in a continuing medical education activity disclose to participants any significant financial interest or other relationship (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation, and (2) with any commercial supporters of the activity.

Dr. Ferrell discloses that she is a member of the speakers bureau for Purdue Pharma, LP, and serves on the advisory board for Watson Pharmaceuticals, Inc.

This monograph was drafted by Andre Weinberger, MD, who has no relationships to disclose. The content of this activity was controlled and approved by the faculty.

To access the Dannemiller site
please click on the logo.
Jointly sponsored by the Dannemiller Memorial Educational Foundation and McMahon Publishing Group.

Sponsored for pharmacists by Purdue University.

This activity is supported through an unrestricted educational grant from Purdue Pharma, LP.

Physicians Licensed in the US Click Here

Physicians Not Licensed in the US and all Others Click Here

Registered Nurses Click Here

Pharmacists Click Here